Izotropic Corp. · CSE:IZO
Izotropic — Investor Presentation (April 2021)
20 slides from Izotropic's investor presentation, April 2021
Slide 1: Izotropic Corporation Investor Presentation April 2021
Gy \) ZOTROPIC 4 CORP RATIO INVESTOR PRESENTATION APRIL 2021 Gizoview
Slide 2: Izotropic Corporation
IZOTROPIC CORPORATION Making Breast CT an indispensable tool for improving the outcomes of br: BREAST CT EVOLUTION GROWING MARKET REGULATORY ¢ $20M spent on R&D to date ¢ Breast imaging market growing from ¢ Patient and payor dem. ¢ Performing prototypes and $3.7B to $5.4B by 2025 new a ongoing clin
Slide 3: Licensed Technology & Intellectual Property
LICENSED TECHNOLOGY & INTELLECTUAL PROPERTY GLOBAL LICENSING RIGHTS * Exclusive worldwide licensing rights to Breast CT through an agreement with The Regents of The University of California * Developed over 20 years by principal technology founder and company director Dr. John M. Boone * Commerciali
Slide 4: True 3D Breast CT Imaging
TRUE 3D BREAST CT IMAGING
Slide 5: U.S. Breast Cancer Landscape
U.S. BREAST CANCER LANDSCAPE 41M BREASTS SCANS IN 2019 280K NEW BREAST CANCER CASES / YE ¢ Screening mammography misses 1/5 cancers _« 1 in 8 women will be diagnosed with breast ¢ Breast cancer is now the most common form cancer in their lifetime, 1 in 39 will die cite lisaeise under" ; ¢ Estimated
Slide 6: Diagnostic Mammography Challenges
DIAGNOSTIC MAMMOGRAPHY CHALLENGES BREAST COMPRESSION * Distorted imaging, patient discomfort, can obscure lesions and tumors * Poor contrast uptake and visualization with compression PATIENT DIGNITY LOSS * Considerable breast handling by technician 2D IMAGING LIMITATIONS * 1 degree view with mammogr
Slide 7: IZOview Breast CT
IZOVIEW BREAST CT A whole new experience for patients, radiologists and providers. NO BREAST COMPRESSION Natural breast orientation preserved, no pain or discomfort, very comfortable face down view, excellent visualization with contrast PATIENT EMPOWERMENT Patient places own breast in imaging cup, n
Slide 8: Contrast-Enhanced Breast CT vs mammography
ontrast-Enhanced Breast CT than both mammography 7 YG izoview True 3D, 360 degree 1 breast CT image slice mm avg. detection size of the 500 obtained CSE: 1ZO OTCQB: IZOZF BREAST CT IMAGING - 8
Slide 9: IZOview Platform Uses
y A IZOVIEW PLATFORM USES Making Breast CT an indispensable tool for improving the outcomes of br SCREENING DIAGNOSTIC BIOPSY TREATMENT f™ ————__ "ae NEWINDICATIONS CURRENT REGULATORY NEW ACCESSORIES NEW DEVICES FOCUS CSE: 1ZO OTCQB: IZOZF BREAST CT IMAGING - 9
Slide 10: Market Acceptance
MARKET ACCEPTANCE Customers are asking for IZOVIEW today. RADIOLOGISTS e Superior image quality ¢ Assessment of breast density & micro-calcifications ¢ True 3D images to rotate PATIENTS ¢ Comfort ¢ Dignity ¢ Speed - 10 seconds PROVIDORS ¢ x3 Patient throughput ¢ Limited training required ¢ Competiti
Slide 11: Commercial Development Pathway
COMMERCIAL DEVELOPMENT PATHWAY PROOF OF RESEARCH & ACADEMIC READY TO CONCEPT PROTOTYPES CLINICAL TRIALS COMMERCIALIZE COMMERCIAL COMMERCIAL CLINICAL CLINICAL REGULATORY DESIGN PROTOTYPE DEVICE STUDY SUBMISSION les W * Design final device and ° Hardware and software * Complete izoview build * Deliver
Slide 12: Current Work Stream Activities
CURRENT WORK STREAM ACTIVITIES Instigating multiple programs to increase speed to market. DEVELOPMENT REIMBURSEMENT « Al software modules and hardware * Expanding payor engagement accessories to expand izoview platform * Collaborating with payors on ¢ Partnerships to accelerate product secondary cli
Slide 13: Directors & Management
DIRECTORS & MANAGEMENT re JOHN MCGRAW, PHD JOHN M. BOONE, PHD BOB THAST CEO Founder & Director Director & Special Advisor Executive in imaging, diagnostic Medical Physicist, Professor, Capital markets specialist, service, and medical device public global speaker, text book strategic planning, busine
Slide 14: Dr. John Boone
DR. JOHN BOONE Principal Founder of Breast CT Technology & Director "We scanned the first patient using cone beam breast CT in 2004, scanned the first cancer patient in early 2005, and performed the first contrast - enhanced breast CT exam in 2006. | take my cues from the breast imaging radiologists
Slide 15: Dr. John McGraw
DR. JOHN MCGRAW Chief Executive Officer "High resolution breast imaging is critical to identifying malignancies as early as possible. Izotropic’s Breast CT has the opportunity to offer patients, with or without dense breasts, a single rapid scan for breast cancer detection in complete comfort and di
Slide 16: Medical & Scientific Advisors
MEDICAL & SCIENTIFIC ADVISORS Internationally Recognized Specialists DR. MARTIN YAFFE PHD Drove the development of digital mammography , Member of The Order of Canada GEORGE BURKETT M.ENG Responsible for the detailed design, mechanical and hardware development of breast CT at UC Davis CSE: 1ZO OTCQB
Slide 17: Market Capitalization
MARKET CAPITALIZATION April 5, 2021 52 WEEK RANGE - CSE: CAD $0.5790 - $1.3100 52 WEEK RANGE - OTC: US $0.5790 - $1.3100 52 WEEK RANGE - FSE: EUR $0.0855 - $1.0200 COMMON SHARES ISSUED - BASIC: 41,981,078 WARRANTS: 6,200,000 @ $0.20 WARRANTS: 6,560,400 @ $0.75 WARRANTS: 1,896,679 @ $1.50 BROKER WARR
Slide 18: Legal
LEGAL SECURITIES COUNSEL: CLARK WILSON LLP https://www.cwilson.com TRUST AGENT: ODYSSEY TRUST https://odysseytrust.com U.S. PATENT COUNSEL: VENABLE LLP https://www.venable.com REGULATORY COUNSEL: BROOKE CONSULTING LLC https://www.brooke-consulting.com CSE: 1ZO OTCQB: IZOZF BREAST CT IMAGING - 18
Slide 19: Citations and Disclaimer
CITATIONS 1, Breast CT Scanner For Earlier Cancer Detection https://ucdavis.pure.elsevier.com/en/projects/breas t-ct-scanner-for-earlier-cancer-detection 2..BMJ: "Every month delayed in cancer treatment can raise risk of death by around 10%." ScienceDaily. ScienceDaily, 4 November 2020 <www.scienced
Slide 20: Investor Relations
INVESTOR RELATIONS: IR@izocorp.com 1-833-IZOCORP ext.1 GENERAL INQUIRIES info@izocorp.com 1-833-IZOCORP ext. 2 izocorp.com VW aizotropic EPeizorropic fH @izotropic BREAST CT IMAGING - 20